as 04-10-2025 11:32am EST
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.
Founded: | 2012 | Country: | United States |
Employees: | N/A | City: | IRVING |
Market Cap: | 136.0M | IPO Year: | N/A |
Target Price: | $8.00 | AVG Volume (30 days): | 327.8K |
Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.09 | EPS Growth: | -30.22 |
52 Week Low/High: | $3.04 - $8.44 | Next Earning Date: | 05-06-2025 |
Revenue: | $197,191,000 | Revenue Growth: | 6.38% |
Revenue Growth (this year): | 6.2% | Revenue Growth (next year): | 9.24% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
HEYER ANDREW R | BTMD | Director | Mar 17 '25 | Buy | $3.95 | 75,000 | $296,042.50 | 1,523,513 | |
Cone Stephen Mark | BTMD | Director | Mar 17 '25 | Buy | $3.88 | 38,104 | $147,843.52 | 160,829 | |
Christensen Bret | BTMD | Chief Executive Officer | Mar 17 '25 | Buy | $3.87 | 37,595 | $145,492.65 | 37,595 | |
Guines LLC | BTMD | 10% Owner | Mar 13 '25 | Buy | $3.48 | 1,713,218 | $5,568,838.51 | 3,927,447 |
BTMD Breaking Stock News: Dive into BTMD Ticker-Specific Updates for Smart Investing
Insider Monkey
8 days ago
Argus Research
21 days ago
Simply Wall St.
21 days ago
Argus Research
22 days ago
Business Wire
23 days ago
Simply Wall St.
a month ago
Thomson Reuters StreetEvents
a month ago
GuruFocus.com
a month ago
The information presented on this page, "BTMD Biote Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.